These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 18486285)

  • 21. [Prevention of influenza by use of intradermal vaccination].
    Kyncl J
    Cas Lek Cesk; 2009; 148(5):191-3. PubMed ID: 19642311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [New vaccination strategies].
    Plotkin SA
    Bull Acad Natl Med; 2008 Mar; 192(3):511-8; discussion 518-9. PubMed ID: 18819697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of nanocarriers for transdermal vaccine delivery.
    Lawson LB; Freytag LC; Clements JD
    Clin Pharmacol Ther; 2007 Dec; 82(6):641-3. PubMed ID: 17998911
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens.
    Perrie Y; Mohammed AR; Kirby DJ; McNeil SE; Bramwell VW
    Int J Pharm; 2008 Dec; 364(2):272-80. PubMed ID: 18555624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A pilot study on intradermal vaccination of Japanese rabies vaccine for pre-exposure immunization.
    Shiota S; Khawplod P; Ahmed K; Mifune K; Nishizono A
    Vaccine; 2008 Nov; 26(50):6441-4. PubMed ID: 18804510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intradermal vaccine immunization.
    Fisher S
    Ann Allergy; 1977 Nov; 39(5):377. PubMed ID: 921007
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunomodulatory biomaterials.
    Mallapragada SK; Narasimhan B
    Int J Pharm; 2008 Dec; 364(2):265-71. PubMed ID: 18662761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Particulate delivery systems for animal vaccines.
    Scheerlinck JP; Greenwood DL
    Methods; 2006 Sep; 40(1):118-24. PubMed ID: 16997719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intradermal vaccination of pigs against FMD with 1/10 dose results in comparable vaccine efficacy as intramuscular vaccination with a full dose.
    Eblé PL; Weerdmeester K; van Hemert-Kluitenberg F; Dekker A
    Vaccine; 2009 Feb; 27(8):1272-8. PubMed ID: 19114077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunogenicity and safety of intradermal versus intramuscular route of influenza immunization in infants less than 6 months of age: a randomized controlled trial.
    Chiu SS; Chan KH; Tu W; Lau YL; Peiris JS
    Vaccine; 2009 Jul; 27(35):4834-9. PubMed ID: 19523908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cutaneous vaccination - Protective immunization is just a skin-deep step away.
    Teunissen MB; Zehrung D
    Vaccine; 2015 Sep; 33(37):4659-62. PubMed ID: 26318246
    [No Abstract]   [Full Text] [Related]  

  • 32. Virus-sized vaccine delivery systems.
    Scheerlinck JP; Greenwood DL
    Drug Discov Today; 2008 Oct; 13(19-20):882-7. PubMed ID: 18656548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nanoparticles for nasal vaccination.
    Csaba N; Garcia-Fuentes M; Alonso MJ
    Adv Drug Deliv Rev; 2009 Feb; 61(2):140-57. PubMed ID: 19121350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current opportunities and challenges in intradermal vaccination.
    Chen D; Bowersock T; Weeratna R; Yeoh T
    Ther Deliv; 2015; 6(9):1101-8. PubMed ID: 26458019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunogenicity and safety of low dose virosomal adjuvanted influenza vaccine administered intradermally compared to intramuscular full dose administration.
    Künzi V; Klap JM; Seiberling MK; Herzog C; Hartmann K; Kürsteiner O; Kompier R; Grimaldi R; Goudsmit J
    Vaccine; 2009 Jun; 27(27):3561-7. PubMed ID: 19464535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Echographic measurement of skin thickness in sites suitable for intradermal vaccine injection in infants and children.
    Ploin D; Schwarzenbach F; Dubray C; Nicolas JF; Goujon C; Trong MD; Laurent PE
    Vaccine; 2011 Oct; 29(46):8438-42. PubMed ID: 21821081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Themed issue: challenges and advances in vaccine delivery: unlocking the pharmaceutical conundrum.
    Jones DS
    J Pharm Pharmacol; 2006 Jun; 58(6):715. PubMed ID: 16734972
    [No Abstract]   [Full Text] [Related]  

  • 38. Foot-and-Mouth Disease Virus neutralizing antibodies production induced by pcDNA3 and Sindbis virus based plasmid encoding FMDV P1-2A3C3D in swine.
    Dory D; Rémond M; Béven V; Cariolet R; Zientara S; Jestin A
    Antiviral Res; 2009 Jul; 83(1):45-52. PubMed ID: 19501256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimization of a jet-propelled particle injection system for the uniform transdermal delivery of drug/vaccine.
    Liu Y; Kendall MA
    Biotechnol Bioeng; 2007 Aug; 97(5):1300-8. PubMed ID: 17216659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Status and future prospects of lipid-based particulate delivery systems as vaccine adjuvants and their combination with immunostimulators.
    Nordly P; Madsen HB; Nielsen HM; Foged C
    Expert Opin Drug Deliv; 2009 Jul; 6(7):657-72. PubMed ID: 19538037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.